文献速递中毒与环境急症呼吸衰竭与机械通气

高流量鼻导管氧疗与常规储氧面罩氧疗在CO中毒中的比较:一项先导研究

Comparison of high-flow nasal cannula oxygen therapy and conventional reserve-bag oxygen therapy in carbon monoxide intoxication: A pilot study.
PubMed 文献 · Am J Emerg Med · 2019-11-06
一句话结论先导RCT显示HFNC(60 L/min)与储氧面罩(15 L/min)相比未降低COHb半衰期,但在轻度CO中毒患者中可能有益。

该先导随机对照试验比较了高流量鼻导管氧疗(HFNC,60 L/min)与常规储氧面罩(NBO2,15 L/min)对轻中度CO中毒患者血中CO清除率的影响。共22例急诊就诊时fCOHb≥10%的患者入组,其中9例fCOHb在25%–50%之间。两组间fCOHb半衰期无显著差异,但HFNC组均值(48.5±12.4 min)标准差小于NBO2组(99.3±93.38 min);在fCOHb<25%的患者中,HFNC组fCOHb半衰期显著短于NBO2组(43.6±10.6 vs 134.2±111.3 min)。作者认为HFNC可能有助于维持稳定的fCOHb半衰期并在轻度CO中毒中缩短半衰期,但需更大样本研究才能确立其作为CO中毒替代疗法的地位。

要点

  • 先导RCT纳入22例急诊fCOHb≥10%的轻中度CO中毒患者,随机接受HFNC(60 L/min)或储氧面罩(15 L/min)100%氧气。
  • 两组总体fCOHb半衰期无显著差异;HFNC组均值48.5±12.4 min,NBO2组99.3±93.38 min。
  • fCOHb<25%的亚组中,HFNC组fCOHb半衰期显著短于NBO2组(43.6±10.6 vs 134.2±111.3 min)。
  • 作者认为HFNC可能有助于维持稳定的fCOHb半衰期,并在轻度CO中毒中缩短半衰期。
  • 作者指出需更大样本研究才能确立HFNC作为CO中毒替代疗法。

适用人群与场景

  • 急诊就诊时fCOHb水平≥10%的轻中度CO中毒患者,共22例,其中9例fCOHb在25%–50%之间。

诊断标准与关键阈值

  • 以急诊就诊时fCOHb≥10%作为入组阈值;每30分钟测量fCOHb直至降至10%以下,据此计算fCOHb半衰期。

处置流程与药物剂量

  • 随机接受100%氧气:储氧面罩(NBO2)流速15 L/min,或HFNC流速60 L/min;每30分钟测fCOHb直至<10%。

研究设计与关键结果

  • 先导随机对照试验,共22例急诊fCOHb≥10%的CO中毒患者,随机分为HFNC组(60 L/min)与NBO2组(15 L/min),均吸入100%氧气。
  • 两组fCOHb半衰期无显著差异;HFNC组均值48.5±12.4 min,NBO2组均值99.3±93.38 min。
  • fCOHb<25%亚组中,HFNC组fCOHb半衰期43.6±10.6 min vs NBO2组134.2±111.3 min,组间差异显著。

证据类型、等级与局限

  • 证据类型:先导随机对照试验。
  • 局限:作者指出需更大样本研究才能确立HFNC作为CO中毒替代疗法。

对床旁实践的改变

  • 作者认为HFNC疗法与常规NBO2疗法相比未降低fCOHb半衰期,但可能有助于维持稳定的fCOHb半衰期,并在轻度CO中毒患者中缩短fCOHb半衰期。
  • 作者指出需更大样本研究才能确立HFNC作为CO中毒患者的替代疗法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: High-flow nasal cannula oxygen (HFNC) creates a positive pressure effect through high-flow rates compared to conventional oxygen therapy. The purpose of this human pilot study is to compare the effects of HFNC and conventional oxygen therapy on the rate of carbon monoxide (CO) clearance from the blood in patients with mild to moderate CO poisoning.

METHODS: CO-poisoned Patients randomly received 100% oxygen from a rebreathing reserve mask (NBO2, flow of 15 L/min) or HFNC (flow of 60 L/min). The fraction of COHb value (fCOHb) was measured in 30-min intervals until it fell to under 10%. We determined the Half-life time of fCOHb (fCOHb t1/2).

RESULTS: A total of 22 patients had fCOHb levels ≥ 10% at the time of ED arrival, with 9 of them having fCOHb level ranging between 25% and 50%. There was no significant difference in the fCOHbt1/2 between the HFNC group and NBO2 group. However, the mean fCOHbt1/2 in the HFNC group (48.5 ± 12.4 min) has a smaller standard deviation than that in the NBO2 group (99.3 ± 93.38 min). There were significant between-group differences in the mean COHbt1/2 among the patients with fCOHb levels less than 25% (HFNC 43.6 ± 10.6 vs. NBO2 134.2 ± 111.3).

CONCLUSIONS: In this pilot randomized controlled trial study, HFNC therapy did not reduce fCOHbt1/2 compared to NBO2 therapy but could be beneficial in maintaining a constant fCOHbt1/2 as well as in reducing fCOHbt1/2 in mild CO poisoning patients compared to conventional NBO2 therapy. However, further studies with a larger number of patients are needed to establish HFNC therapy as an alternative therapy for CO poisoning patients.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kim YM, Shin HJ, Choi DW, et al. Comparison of high-flow nasal cannula oxygen therapy and conventional reserve-bag oxygen therapy in carbon monoxide intoxication: A pilot study. Am J Emerg Med. 2019. PMID: 31706658. doi:10.1016/j.ajem.2019.158451

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。